Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Make a selection below to explore our full database of 3 results matching: "P Lakatos"
ACE Reports
(3 Reports)
ACE Reports
Our Al driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Metabolic Disorders
WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide
WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide
Osteoarthritis
Zoledronic acid has no continued benefit beyond 6 years for osteoporosis
J Bone Miner Res. 2015 May;30(5):934-44.
Zoledronic acid has no continued benefit beyond 6 years for osteoporosis
J Bone Miner Res. 2015 May;30(5):934-44.
General Orthopaedics
The effect of 3 versus 6 years of zoledronic acid treatment on femoral neck-BMD
J Bone Miner Res. 2012 Feb;27(2):243-54. doi: 10.1002/jbmr.1494
The effect of 3 versus 6 years of zoledronic acid treatment on femoral neck-BMD
J Bone Miner Res. 2012 Feb;27(2):243-54. doi: 10.1002/jbmr.1494